{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:51:44Z","timestamp":1783605104971,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Fondation du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al"},{"DOI":"10.13039\/501100000024","name":"Canadian Institute of Health Research","doi-asserted-by":"crossref","award":["PJT-148709"],"award-info":[{"award-number":["PJT-148709"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jpba.2020.113521","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T02:35:03Z","timestamp":1597458903000},"page":"113521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Development and validation of a liquid chromatography coupled to tandem mass spectrometry method for the simultaneous quantification of five analgesics and sedatives, and six of their active metabolites in human plasma: Application to a clinical study on the determination of neurological death in the intensive care unit"],"prefix":"10.1016","volume":"190","author":[{"given":"Martin","family":"Jutras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Chass\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Leclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2020.113521_bib0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00134-015-4191-5","article-title":"Organ donation in adults: a critical care perspective","volume":"42","author":"Citerio","year":"2016","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jpba.2020.113521_bib0010","first-page":"64","article-title":"Guidelines for the diagnosis of brain death, Canadian Neurocritical Care Group","volume":"26","year":"1999","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jpba.2020.113521_bib0015","first-page":"171","article-title":"Management of severe traumatic brain injury (first 24 hours)","volume":"37","author":"Geeraerts","year":"2018","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"10.1016\/j.jpba.2020.113521_bib0020","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1503\/cmaj.045142","article-title":"Severe brain injury to neurological determination of death: canadian forum recommendations","volume":"174","author":"Shemie","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.jpba.2020.113521_bib0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12028-009-9231-y","article-title":"Pitfalls in the diagnosis of brain death","volume":"11","author":"Busl","year":"2009","journal-title":"Neurocrit. Care"},{"key":"10.1016\/j.jpba.2020.113521_bib0030","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.clinthera.2018.07.021","article-title":"Altered pharmacokinetics in prolonged infusions of sedatives and analgesics among adult critically ill patients: a Systematic Review","volume":"40","author":"Tse","year":"2018","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jpba.2020.113521_bib0035","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s12630-014-0174-1","article-title":"Analgesic, sedative, antipsychotic, and neuromuscular blocker use in Canadian intensive care units: a prospective, multicentre, observational study","volume":"61","author":"Burry","year":"2014","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.jpba.2020.113521_bib0040","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jpba.2020.113521_bib0045","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1592\/phco.27.3.389","article-title":"Clinical pharmacokinetic monitoring of midazolam in critically ill patients","volume":"27","author":"Spina","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jpba.2020.113521_bib0050","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1248\/yakushi.123.811","article-title":"Possibility of influence of midazolam sedation on the diagnosis of brain death: concentrations of active metabolites after cessation of midazolam","volume":"123","author":"Hirata","year":"2003","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.jpba.2020.113521_bib0055","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5414\/CPP43517","article-title":"Midazolam and its metabolites in brain death diagnosis","volume":"43","author":"Meinitzer","year":"2005","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2020.113521_bib0060","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jchromb.2012.07.005","article-title":"High-throughput assay for simultaneous quantification of the plasma concentrations of morphine, fentanyl, midazolam and their major metabolites using automated SPE coupled to LC\u2013MS\/MS","volume":"903","author":"Ghassabian","year":"2012","journal-title":"J Chromat B"},{"key":"10.1016\/j.jpba.2020.113521_bib0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1124\/dmd.112.045567","article-title":"Effect of Hypothermia on the disposition of morphine, midazolam, fentanyl, and propofol in intensive care unit patients","volume":"41","author":"Bjelland","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2020.113521_bib0070","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/bmc.1394","article-title":"Quantification of midazolam, morphine and metabolites in plasma using 96-well solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry","volume":"249","author":"Ahsman","year":"2010","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2020.113521_bib0075","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.clinbiochem.2015.05.023","article-title":"The development of a high-performance liquid chromatography\u2013tandem mass spectrometric method for simultaneous quantification of morphine, morphine-3-\u03b2-glucuronide, morphine-6-\u03b2-glucuronide, hydromorphone, and normorphine in serum","volume":"48","author":"Sartori","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jpba.2020.113521_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2015.06.028","article-title":"Development of a new multi-analyte assay for the simultaneous detection of opioids in serum and other body fluids using liquid chromatography-tandem mass spectrometry","volume":"1001","author":"Eckart","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2020.113521_bib0085","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jpba.2017.11.035","article-title":"Bioanalytical methods for the quantification of hydromorphone, fentanyl, norfentanyl, morphine, morphine-3B-glucuronide, and morphine-6B-glucuronide in human plasma","volume":"149","author":"de Bruijn","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113521_bib0090","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00414-014-1040-y","article-title":"Quantitative low-volume assay for simultaneous determination of fentanyl, norfentanyl, and minor metabolites in human plasma and urine by liquid chromatography-tandem mass spectrometry (LC\u2013MS\/MS)","volume":"128","author":"Mahlke","year":"2014","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.jpba.2020.113521_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2017.09.030","article-title":"Development and validation of a sensitive assay for analysis of midazolam, free and conjugated 1-hydroxymidazolam and 4-hydroxymidazolam in pediatric plasma: application to pediatric pharmacokinetic study","volume":"1067","author":"Moorthy","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2020.113521_bib0100","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/rcm.2987","article-title":"Determination of midazolam and its hydroxy metabolites in human plasma and oral fluid by liquid chromatography\/electrospray ionization ion trap tandem mass spectrometry","volume":"21","author":"Link","year":"2007","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2020.113521_bib0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jchromb.2007.04.021","article-title":"Quantitative measurement of propofol and in main glucuroconjugate metabolites in human plasma using solid phase extraction-liquid chromatography-tandem mass spectrometry","volume":"854","author":"Cohen","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2020.113521_bib0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1570-0232(04)00661-0","article-title":"A new method for the quantitation of propofol in human plasma: efficient solid-phase extraction and liquid chromatography\/APCI-triple quadrupole mass spectrometry detection","volume":"810","author":"Bajpai","year":"2004","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2020.113521_bib0115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jpba.2015.02.035","article-title":"Simultaneous determination of propofol and its glucuronide in whole blood by liquid chromatography-electrospray tandem mass spectrometry and the influence of sample storage conditions on the reliability of the test results","volume":"109","author":"S\u00f8rensen","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113521_bib0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jpba.2016.04.026","article-title":"Determination of total and unbound propofol in patients during intensive care sedation by ultrafiltration and LC-MS\/MS","volume":"126","author":"Eisenried","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113521_bib0125","series-title":"Guidance for Industry, Bioanalytical Method Validation","author":"U.S Department of Health and Human Services, Food and Drug Administration","year":"2018"},{"key":"10.1016\/j.jpba.2020.113521_bib0130","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.4155\/bio.14.164","article-title":"Current position of high-resolution MS for drug quantification in clinical & forensic toxicology","volume":"6","author":"Meyer","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2020.113521_bib0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0378-4347(98)00466-6","article-title":"Direct high-performance liquid chromatography determination of propofol and its metabolite quinol with their glucuronide conjugates and preliminary pharmacokinetics in plasma and urine of man","volume":"721","author":"Vree","year":"1999","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jpba.2020.113521_bib0140","series-title":"Efficient and Clean Extraction of a Multi-drug Panel With Oasis PRiME MCX","author":"Danaceau","year":"2018"},{"key":"10.1016\/j.jpba.2020.113521_bib0145","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4155\/bio.13.109","article-title":"Severe impact of hemolysis on stability of phenolic compounds","volume":"5","author":"B\u00e9rub\u00e9","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2020.113521_bib0150","first-page":"95","article-title":"Long-term stability of propofol in human plasma and blood in different storage conditions","volume":"62","author":"Bienert","year":"2005","journal-title":"Acta Pol. Pharm."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520314072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520314072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:09:09Z","timestamp":1760000949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708520314072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":30,"alternative-id":["S0731708520314072"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113521","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a liquid chromatography coupled to tandem mass spectrometry method for the simultaneous quantification of five analgesics and sedatives, and six of their active metabolites in human plasma: Application to a clinical study on the determination of neurological death in the intensive care unit","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113521"}}